Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070

BACKGROUND: Despite intensive research and novel adjuvant therapies, there is currently no cure for metastatic melanoma. The chemokine receptor CXCR4 controls metastasis to sites such as the liver; however, the therapeutic blockade with the existing agents has proven difficult. METHODS: AMD11070, a...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Boyle, G, Swidenbank, I, Marshall, H, Barker, C E, Armstrong, J, White, S A, Fricker, S P, Plummer, R, Wright, M, Lovat, P E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668477/
https://www.ncbi.nlm.nih.gov/pubmed/23538388
http://dx.doi.org/10.1038/bjc.2013.124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668477/
https://www.ncbi.nlm.nih.gov/pubmed/23538388
http://dx.doi.org/10.1038/bjc.2013.124

Ejemplares similares